CLINICAL TRIAL IN INDIA: RISE AND FALL
Journal Title: International Journal of Drug Regulatory Affairs - Year 2015, Vol 3, Issue 1
Abstract
Fight with the disease is the ever evolving frontier for human beings. Discovery of new drugs and devices through clinical research are the armory to help in the fight with the affliction of mankind. Clinical trials, test potential treatments in human volunteers to see whether they should be approved for wider use in the general population. A treatment could be a drug, medical device, or biologic, such as a vaccine, blood product, or gene therapy. India stood as a global hub for clinical trials in past years. Later, the amendments made in Indian regulations paved for the decline of clinical trials. The aim of this article is to provide the details about the Indian clinical trial application filing process, the amendments made in its regulations and the challenges faced by Indian clinical trial industry.
Authors and Affiliations
Chitral Kulshreshtha, Venkatesh M P, Shrisha K, Pramod Kumar T M
Keywords
Related Articles
- EP ID EP338314
- DOI -
- Views 95
- Downloads 0
PREPARATION & COMPILATION OF ACTD DOSSIER (PART II QUALITY)
ACTD is a critical document for drug substance and produces registration in ASEAN region. The document is essentially divided into 4 parts. Each part provides information under specific head. Out of all the parts, the pa...
Preliminary requirement for ANDA Filing
USFDA is very critical regulated agency for submission. This review reveals how to submit an Abbreviated New Drug Application (ANDA) as per FDA under section 505(j) of the Federal Food, Drug, and Cosmetic Act (FD&C Act)...
A COMPREHENSION STUDY ON REGULATION OF HERBAL DRUGS IN USA, EUROPEAN UNION AND INDIA
The present study reviews the regulations of herbal drugs in the EU, US and India and throws light upon issues related to their clinical trials. Herbal drugs have been used for a long time in different systems of health...
FEEBLE REGULATORY AFFAIRS WEAKEN THE BACKBONE OF INDIAN DRUG INDUSTRIES
India is emerging as a global outsourcing power house in almost all fields including Drugs and Pharmaceutical sector. Now it becomes a hub to conduct clinical trials and contract researches. Pharmaceutical industry curre...
EXCLUSIVITY STRATEGIES OF INNOVATOR DRUG DEVELOPERS
Pharmaceutical drug development had become very costly and time consuming. There is an estimate that a drug from molecular development to marketing approvals cost $800 Millions. Drug approval process is time consuming pr...